{"gene":"TSSK2","run_date":"2026-06-10T10:51:56","timeline":{"discoveries":[{"year":2008,"finding":"TSSK2 physically interacts with the axoneme central apparatus protein SPAG16L via the C-terminal WD-repeat domain of SPAG16L; the N-terminal coiled-coil domain does not associate with TSSK2. TSSK2 phosphorylates SPAG16L in vitro, identifying SPAG16L as a TSSK2 substrate. Additionally, TSSK2 protein is absent or markedly reduced in testes of SPAG16L-null mice.","method":"Yeast two-hybrid screen, co-immunoprecipitation from testis extracts and co-expressing cell lysates, confocal colocalization, in vitro kinase assay, domain-mapping experiments, immunoblot of knockout mouse testes","journal":"Biology of reproduction","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — multiple orthogonal methods (Y2H, reciprocal Co-IP, in vitro kinase assay, domain mapping, KO mouse validation) in a single focused study","pmids":["18367677"],"is_preprint":false},{"year":2016,"finding":"Recombinant human TSSK2 produced in baculovirus is enzymatically active, phosphorylating hTSKS isoform 2, casein, and glycogen synthase peptide in vitro. The N-terminal region (aa 1–150) of TSKS is particularly strongly phosphorylated, localizing the primary TSSK2 phosphorylation site to the N-terminus of human TSKS. ATP Km is ~2.2–2.7 µM; staurosporine inhibits hTSSK2 with IC50 = 20 nM.","method":"Baculovirus expression, IMAC and gel-filtration purification, in vitro kinase assay, mobility shift assay, TSKS fragment phosphorylation mapping","journal":"Protein expression and purification","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution with substrate mapping and kinetic parameters, single lab but multiple orthogonal assays","pmids":["26777341"],"is_preprint":false},{"year":2017,"finding":"High-throughput mobility-shift kinase assay identified pyrrolopyrimidine and pyrimidine inhibitors of TSSK2 with sub-100 nM potency (best IC50 values: 22 nM and 31 nM). Compound 19 displayed selectivity rank order TSSK1 > TSSK2 > TSSK3 > TSSK6, demonstrating that potent dual TSSK1/2 inhibitors can be identified and that TSSK2 is an inhibitable serine/threonine kinase.","method":"High-throughput mobility shift assay (~17,000 compounds), IC50 determination across TSSK isoforms","journal":"ChemMedChem","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — biochemical assay with multiple inhibitor series and isoform selectivity profiling, single lab","pmids":["28952188"],"is_preprint":false},{"year":2012,"finding":"Functional analysis of TSSK2 replacement mutation K27R (frequently observed in humans) was performed; the C-terminal domain of TSSK1B (but not TSSK2) shows evidence of positive selection in primates, suggesting TSSK1B and TSSK2 perform at least partly differential functions. The kinase domains of both TSSK1B and TSSK2 evolved under negative (purifying) selection, consistent with requirement to maintain kinase activity.","method":"Evolutionary sequence analysis with functional mutagenesis of K27R variant; comparative genomics in primates","journal":"Andrology","confidence":"Low","confidence_rationale":"Tier 4 / Weak — primarily computational/evolutionary analysis; mutagenesis result not described with biochemical readout in the abstract","pmids":["23258646"],"is_preprint":false},{"year":2012,"finding":"Immunofluorescence localization of TSSK2 in mouse sperm showed predominant distribution in the post-acrosomal region, while in human sperm TSSK2 was found in the equatorial region. TSSK2 distribution was unchanged after acrosome reaction, distinguishing it from TSSK1.","method":"Western blot (mature mouse and human sperm), immunofluorescence on non-capacitated, capacitated, and acrosome-reacted sperm","journal":"Dong wu xue yan jiu = Zoological research","confidence":"Low","confidence_rationale":"Tier 3 / Weak — localization data from a single lab with no functional consequence directly linked to TSSK2 specifically","pmids":["22855445"],"is_preprint":false},{"year":2025,"finding":"CRISPR/Cas9-generated Tssk2 homozygous mutant male mice are sterile with lower sperm numbers and decreased motility, establishing that TSSK2 is individually essential for male reproduction independently of TSSK1. Anti-TSSK2 antibodies validated against Tssk2 mutants confirmed TSSK2 localization to the sperm head; TSSK2 is present in testes and sperm of Tssk1 mutant mice, confirming independent function.","method":"CRISPR/Cas9 knockout mouse generation, natural mating fertility assay, in vitro fertilization, sperm count and motility analysis, Western blot, immunofluorescence with validated antibody","journal":"Biomolecules","confidence":"High","confidence_rationale":"Tier 2 / Strong — independent KO mouse lines with orthogonal phenotypic readouts (fertility, sperm count, motility, IVF) and validated antibody localization","pmids":["40305308"],"is_preprint":false},{"year":2025,"finding":"TSSK2 is a component of the late chromatoid body (late-CB) in elongating spermatids. Proteomics and RNA-interaction studies showed TSSK2 associates with translation initiation factors and ribosomal proteins, and co-precipitates a specific set of mRNAs that are enriched in polysome fractions in elongating spermatids, linking the late-CB and TSSK2 to temporally regulated translation during late spermatogenesis.","method":"Identification of TSSK2-interacting proteins and RNAs (RNP pulldown/mass spectrometry implied), polysome fractionation, late-CB marker co-localization","journal":"Reproduction (Cambridge, England)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal approaches (protein interaction, RNA interaction, polysome fractionation) in single study; abstract does not fully detail all methods","pmids":["41042594"],"is_preprint":false},{"year":2026,"finding":"Targeted degraders (PROTACs) directed against TSSK2 reduced TSSK2 protein levels by up to 80% in ex vivo mouse sperm within 4 hours, causing a 97% reduction in sperm motility and near-complete loss of in vitro fertilization capacity, demonstrating that acute loss of TSSK2 kinase is sufficient to abrogate sperm motility and fertilizing ability.","method":"Targeted protein degrader (PROTAC) treatment of ex vivo CD1 mouse sperm, quantitative Western blot (HiBiT), sperm motility assay, in vitro fertilization assay","journal":"Journal of medicinal chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — chemical knockdown in native sperm with quantitative protein reduction and two orthogonal functional readouts (motility and IVF), single lab","pmids":["42228803"],"is_preprint":false}],"current_model":"TSSK2 is a testis-specific serine/threonine kinase expressed post-meiotically in elongating spermatids and localized to the sperm head/post-acrosomal region; it phosphorylates the axoneme protein SPAG16L and the N-terminal domain of TSKS, associates with translation initiation factors and ribosomal proteins as part of the late chromatoid body to regulate mRNA translation during late spermatogenesis, and is individually essential for sperm motility, sperm number, and male fertility as demonstrated by CRISPR knockout and acute targeted degradation in sperm."},"narrative":{"mechanistic_narrative":"TSSK2 is a testis-specific serine/threonine protein kinase that is individually essential for sperm motility, sperm number, and male fertility [PMID:40305308]. Recombinant human TSSK2 is enzymatically active with a low ATP Km and is potently inhibited by staurosporine and by pyrrolopyrimidine/pyrimidine small molecules at sub-100 nM potency [PMID:26777341, PMID:28952188]. Its identified substrates include the axoneme central-apparatus protein SPAG16L, which it binds via the SPAG16L C-terminal WD-repeat domain and phosphorylates in vitro, and the N-terminal region (aa 1–150) of TSKS [PMID:18367677, PMID:26777341]; TSSK2 protein is markedly reduced in SPAG16L-null testes, indicating that the interaction also stabilizes TSSK2 [PMID:18367677]. In elongating spermatids TSSK2 is a component of the late chromatoid body, where it associates with translation initiation factors and ribosomal proteins and co-precipitates a defined set of polysome-enriched mRNAs, linking the kinase to temporally regulated translation during late spermatogenesis [PMID:41042594]. Genetic ablation produces sterile males with reduced and poorly motile sperm, and acute PROTAC-mediated degradation of TSSK2 in ex vivo sperm collapses motility and fertilizing capacity within hours, establishing that ongoing TSSK2 kinase activity is required for sperm function [PMID:40305308, PMID:42228803].","teleology":[{"year":2008,"claim":"Established the first molecular substrate and binding partner of TSSK2, connecting the kinase to the sperm axoneme.","evidence":"Yeast two-hybrid, reciprocal Co-IP, in vitro kinase assay, domain mapping, and KO mouse immunoblot identifying SPAG16L","pmids":["18367677"],"confidence":"High","gaps":["Phosphosite on SPAG16L not mapped","Functional consequence of SPAG16L phosphorylation in vivo not tested"]},{"year":2012,"claim":"Defined the subcellular distribution of TSSK2 in mature sperm and distinguished it from TSSK1.","evidence":"Immunofluorescence of non-capacitated, capacitated, and acrosome-reacted mouse and human sperm","pmids":["22855445"],"confidence":"Low","gaps":["No functional consequence directly tied to TSSK2 localization","Species difference (post-acrosomal vs equatorial) unexplained"]},{"year":2012,"claim":"Addressed whether TSSK2 and its paralog TSSK1B are functionally redundant by comparing selective pressures and a human variant.","evidence":"Comparative primate genomics with functional mutagenesis of the K27R variant","pmids":["23258646"],"confidence":"Low","gaps":["K27R mutagenesis lacks a described biochemical readout","Differential function inferred from evolution, not directly demonstrated"]},{"year":2016,"claim":"Confirmed TSSK2 is an active kinase with defined substrates and kinetics, mapping its primary site on TSKS.","evidence":"Baculovirus-expressed recombinant human TSSK2, in vitro kinase assays, TSKS fragment phosphorylation mapping, ATP Km and staurosporine IC50 determination","pmids":["26777341"],"confidence":"High","gaps":["Physiological role of TSKS phosphorylation not established","No structural model of the active kinase"]},{"year":2017,"claim":"Demonstrated TSSK2 is a chemically tractable target and profiled inhibitor selectivity across TSSK isoforms.","evidence":"High-throughput mobility-shift screen of ~17,000 compounds with IC50 profiling across TSSK1/2/3/6","pmids":["28952188"],"confidence":"Medium","gaps":["Inhibitor activity in sperm not tested in this study","Selectivity against the broader kinome not reported"]},{"year":2025,"claim":"Established that TSSK2 is individually essential for male fertility, independent of TSSK1.","evidence":"CRISPR/Cas9 knockout mice, mating and IVF fertility assays, sperm count and motility analysis, validated-antibody immunofluorescence","pmids":["40305308"],"confidence":"High","gaps":["Molecular cause of the motility/count defect not resolved","Stage at which spermatogenesis fails not pinpointed"]},{"year":2025,"claim":"Placed TSSK2 in the late chromatoid body and linked it to temporally regulated mRNA translation in elongating spermatids.","evidence":"Protein and RNA interaction profiling, polysome fractionation, late-CB marker co-localization","pmids":["41042594"],"confidence":"Medium","gaps":["Whether TSSK2 kinase activity controls the associated translation not shown","Identity of functionally relevant mRNA targets not validated"]},{"year":2026,"claim":"Showed that acute, post-developmental loss of TSSK2 protein is sufficient to abolish sperm motility and fertilization, validating it as a non-hormonal contraceptive target.","evidence":"PROTAC-mediated degradation in ex vivo mouse sperm with HiBiT quantification, motility and IVF readouts","pmids":["42228803"],"confidence":"High","gaps":["Reversibility and in vivo efficacy not addressed","Mechanism linking acute kinase loss to motility collapse not defined"]},{"year":null,"claim":"How TSSK2 kinase activity mechanistically couples its substrates (SPAG16L, TSKS) and its chromatoid-body translational role to sperm motility remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No in vivo phosphosite-mutant rescue connecting substrate phosphorylation to motility","Causal link between late-CB translation and the knockout phenotype untested","Structure of TSSK2 and its substrate-recognition basis unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0,1,2]},{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[0,1]},{"term_id":"GO:0003723","term_label":"RNA binding","supporting_discovery_ids":[6]}],"localization":[{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[6]}],"pathway":[{"term_id":"R-HSA-1474165","term_label":"Reproduction","supporting_discovery_ids":[5,7]},{"term_id":"R-HSA-8953854","term_label":"Metabolism of RNA","supporting_discovery_ids":[6]}],"complexes":["late chromatoid body"],"partners":["SPAG16L","TSKS"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q96PF2","full_name":"Testis-specific serine/threonine-protein kinase 2","aliases":["DiGeorge syndrome protein G","DGS-G","Serine/threonine-protein kinase 22B"],"length_aa":358,"mass_kda":40.9,"function":"Testis-specific serine/threonine-protein kinase required during spermatid development. Phosphorylates TSKS at 'Ser-288' and SPAG16. Involved in the late stages of spermatogenesis, during the reconstruction of the cytoplasm. During spermatogenesis, required for the transformation of a ring-shaped structure around the base of the flagellum originating from the chromatoid body","subcellular_location":"Cytoplasm; Cytoplasm, cytoskeleton, microtubule organizing center, centrosome, centriole","url":"https://www.uniprot.org/uniprotkb/Q96PF2/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/TSSK2","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/TSSK2","total_profiled":1310},"omim":[{"mim_id":"610710","title":"TESTIS-SPECIFIC SERINE/THREONINE KINASE 2; TSSK2","url":"https://www.omim.org/entry/610710"},{"mim_id":"610709","title":"TESTIS-SPECIFIC SERINE/THREONINE KINASE 1; TSSK1","url":"https://www.omim.org/entry/610709"},{"mim_id":"608253","title":"TESTIS-SPECIFIC KINASE SUBSTRATE; TSKS","url":"https://www.omim.org/entry/608253"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in single","driving_tissues":[{"tissue":"testis","ntpm":181.0}],"url":"https://www.proteinatlas.org/search/TSSK2"},"hgnc":{"alias_symbol":["SPOGA2","FLJ38613"],"prev_symbol":["STK22B"]},"alphafold":{"accession":"Q96PF2","domains":[{"cath_id":"3.30.200.20","chopping":"2-89","consensus_level":"high","plddt":92.58,"start":2,"end":89},{"cath_id":"1.10.510.10","chopping":"95-273_321-334","consensus_level":"high","plddt":93.4142,"start":95,"end":334}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q96PF2","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q96PF2-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q96PF2-F1-predicted_aligned_error_v6.png","plddt_mean":82.44},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=TSSK2","jax_strain_url":"https://www.jax.org/strain/search?query=TSSK2"},"sequence":{"accession":"Q96PF2","fasta_url":"https://rest.uniprot.org/uniprotkb/Q96PF2.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q96PF2/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q96PF2"}},"corpus_meta":[{"pmid":"18367677","id":"PMC_18367677","title":"Phosphorylation of mouse sperm axoneme central apparatus protein SPAG16L by a testis-specific kinase, TSSK2.","date":"2008","source":"Biology of reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/18367677","citation_count":25,"is_preprint":false},{"pmid":"32046715","id":"PMC_32046715","title":"Effects of Qilin pills on spermatogenesis, reproductive hormones, oxidative stress, and the TSSK2 gene in a rat model of oligoasthenospermia.","date":"2020","source":"BMC complementary medicine and therapies","url":"https://pubmed.ncbi.nlm.nih.gov/32046715","citation_count":25,"is_preprint":false},{"pmid":"19926886","id":"PMC_19926886","title":"Some single-nucleotide polymorphisms of the TSSK2 gene may be associated with human spermatogenesis impairment.","date":"2009","source":"Journal of andrology","url":"https://pubmed.ncbi.nlm.nih.gov/19926886","citation_count":20,"is_preprint":false},{"pmid":"28952188","id":"PMC_28952188","title":"Potent Pyrimidine and Pyrrolopyrimidine Inhibitors of Testis-Specific Serine/Threonine Kinase 2 (TSSK2).","date":"2017","source":"ChemMedChem","url":"https://pubmed.ncbi.nlm.nih.gov/28952188","citation_count":19,"is_preprint":false},{"pmid":"23258646","id":"PMC_23258646","title":"Evolution of testis-specific kinases TSSK1B and TSSK2 in primates.","date":"2012","source":"Andrology","url":"https://pubmed.ncbi.nlm.nih.gov/23258646","citation_count":15,"is_preprint":false},{"pmid":"34041241","id":"PMC_34041241","title":"Long Noncoding RNA lnc-TSSK2-8 Activates Canonical Wnt/β-Catenin Signaling Through Small Heat Shock Proteins HSPA6 and CRYAB.","date":"2021","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/34041241","citation_count":9,"is_preprint":false},{"pmid":"26777341","id":"PMC_26777341","title":"Recombinant production of enzymatically active male contraceptive drug target hTSSK2 - Localization of the TSKS domain phosphorylated by TSSK2.","date":"2016","source":"Protein expression and purification","url":"https://pubmed.ncbi.nlm.nih.gov/26777341","citation_count":7,"is_preprint":false},{"pmid":"40305308","id":"PMC_40305308","title":"Identification of TSSK1 and TSSK2 as Novel Targets for Male Contraception.","date":"2025","source":"Biomolecules","url":"https://pubmed.ncbi.nlm.nih.gov/40305308","citation_count":5,"is_preprint":false},{"pmid":"38783691","id":"PMC_38783691","title":"CRISPR/Cas9 mediated validation of spermatogenesis-related gene, tssk2 as a component of genetic pest management of fall armyworm, Spodoptera frugiperda (J. E. Smith) (Lepidoptera: Noctuidae).","date":"2024","source":"Archives of insect biochemistry and physiology","url":"https://pubmed.ncbi.nlm.nih.gov/38783691","citation_count":4,"is_preprint":false},{"pmid":"22855445","id":"PMC_22855445","title":"[Cloning and expression of Tssk1 & Tssk2 in mice and the presence & localization of them in mature sperm].","date":"2012","source":"Dong wu xue yan jiu = Zoological research","url":"https://pubmed.ncbi.nlm.nih.gov/22855445","citation_count":3,"is_preprint":false},{"pmid":"41042594","id":"PMC_41042594","title":"The late chromatoid body component TSSK2 is involved in translational regulation in elongating spermatids in mice.","date":"2025","source":"Reproduction (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/41042594","citation_count":0,"is_preprint":false},{"pmid":"42228803","id":"PMC_42228803","title":"Development of TSSK1 and TSSK2 Targeted Degraders Reveals Sperm Machinery for Protein Degradation and Potential for Nonhormonal Male Contraception.","date":"2026","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/42228803","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":8001,"output_tokens":2293,"usd":0.029199,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":9330,"output_tokens":2606,"usd":0.0559,"stage2_stop_reason":"end_turn"},"total_usd":0.085099,"stage1_batch_id":"msgbatch_017qqVz33Ga63SCDwzb35XPb","stage2_batch_id":"msgbatch_01Scr2Ei9x4HJMiRGxwrmvLK","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2008,\n      \"finding\": \"TSSK2 physically interacts with the axoneme central apparatus protein SPAG16L via the C-terminal WD-repeat domain of SPAG16L; the N-terminal coiled-coil domain does not associate with TSSK2. TSSK2 phosphorylates SPAG16L in vitro, identifying SPAG16L as a TSSK2 substrate. Additionally, TSSK2 protein is absent or markedly reduced in testes of SPAG16L-null mice.\",\n      \"method\": \"Yeast two-hybrid screen, co-immunoprecipitation from testis extracts and co-expressing cell lysates, confocal colocalization, in vitro kinase assay, domain-mapping experiments, immunoblot of knockout mouse testes\",\n      \"journal\": \"Biology of reproduction\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — multiple orthogonal methods (Y2H, reciprocal Co-IP, in vitro kinase assay, domain mapping, KO mouse validation) in a single focused study\",\n      \"pmids\": [\"18367677\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Recombinant human TSSK2 produced in baculovirus is enzymatically active, phosphorylating hTSKS isoform 2, casein, and glycogen synthase peptide in vitro. The N-terminal region (aa 1–150) of TSKS is particularly strongly phosphorylated, localizing the primary TSSK2 phosphorylation site to the N-terminus of human TSKS. ATP Km is ~2.2–2.7 µM; staurosporine inhibits hTSSK2 with IC50 = 20 nM.\",\n      \"method\": \"Baculovirus expression, IMAC and gel-filtration purification, in vitro kinase assay, mobility shift assay, TSKS fragment phosphorylation mapping\",\n      \"journal\": \"Protein expression and purification\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution with substrate mapping and kinetic parameters, single lab but multiple orthogonal assays\",\n      \"pmids\": [\"26777341\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"High-throughput mobility-shift kinase assay identified pyrrolopyrimidine and pyrimidine inhibitors of TSSK2 with sub-100 nM potency (best IC50 values: 22 nM and 31 nM). Compound 19 displayed selectivity rank order TSSK1 > TSSK2 > TSSK3 > TSSK6, demonstrating that potent dual TSSK1/2 inhibitors can be identified and that TSSK2 is an inhibitable serine/threonine kinase.\",\n      \"method\": \"High-throughput mobility shift assay (~17,000 compounds), IC50 determination across TSSK isoforms\",\n      \"journal\": \"ChemMedChem\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — biochemical assay with multiple inhibitor series and isoform selectivity profiling, single lab\",\n      \"pmids\": [\"28952188\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Functional analysis of TSSK2 replacement mutation K27R (frequently observed in humans) was performed; the C-terminal domain of TSSK1B (but not TSSK2) shows evidence of positive selection in primates, suggesting TSSK1B and TSSK2 perform at least partly differential functions. The kinase domains of both TSSK1B and TSSK2 evolved under negative (purifying) selection, consistent with requirement to maintain kinase activity.\",\n      \"method\": \"Evolutionary sequence analysis with functional mutagenesis of K27R variant; comparative genomics in primates\",\n      \"journal\": \"Andrology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 4 / Weak — primarily computational/evolutionary analysis; mutagenesis result not described with biochemical readout in the abstract\",\n      \"pmids\": [\"23258646\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Immunofluorescence localization of TSSK2 in mouse sperm showed predominant distribution in the post-acrosomal region, while in human sperm TSSK2 was found in the equatorial region. TSSK2 distribution was unchanged after acrosome reaction, distinguishing it from TSSK1.\",\n      \"method\": \"Western blot (mature mouse and human sperm), immunofluorescence on non-capacitated, capacitated, and acrosome-reacted sperm\",\n      \"journal\": \"Dong wu xue yan jiu = Zoological research\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — localization data from a single lab with no functional consequence directly linked to TSSK2 specifically\",\n      \"pmids\": [\"22855445\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"CRISPR/Cas9-generated Tssk2 homozygous mutant male mice are sterile with lower sperm numbers and decreased motility, establishing that TSSK2 is individually essential for male reproduction independently of TSSK1. Anti-TSSK2 antibodies validated against Tssk2 mutants confirmed TSSK2 localization to the sperm head; TSSK2 is present in testes and sperm of Tssk1 mutant mice, confirming independent function.\",\n      \"method\": \"CRISPR/Cas9 knockout mouse generation, natural mating fertility assay, in vitro fertilization, sperm count and motility analysis, Western blot, immunofluorescence with validated antibody\",\n      \"journal\": \"Biomolecules\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — independent KO mouse lines with orthogonal phenotypic readouts (fertility, sperm count, motility, IVF) and validated antibody localization\",\n      \"pmids\": [\"40305308\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"TSSK2 is a component of the late chromatoid body (late-CB) in elongating spermatids. Proteomics and RNA-interaction studies showed TSSK2 associates with translation initiation factors and ribosomal proteins, and co-precipitates a specific set of mRNAs that are enriched in polysome fractions in elongating spermatids, linking the late-CB and TSSK2 to temporally regulated translation during late spermatogenesis.\",\n      \"method\": \"Identification of TSSK2-interacting proteins and RNAs (RNP pulldown/mass spectrometry implied), polysome fractionation, late-CB marker co-localization\",\n      \"journal\": \"Reproduction (Cambridge, England)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal approaches (protein interaction, RNA interaction, polysome fractionation) in single study; abstract does not fully detail all methods\",\n      \"pmids\": [\"41042594\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"Targeted degraders (PROTACs) directed against TSSK2 reduced TSSK2 protein levels by up to 80% in ex vivo mouse sperm within 4 hours, causing a 97% reduction in sperm motility and near-complete loss of in vitro fertilization capacity, demonstrating that acute loss of TSSK2 kinase is sufficient to abrogate sperm motility and fertilizing ability.\",\n      \"method\": \"Targeted protein degrader (PROTAC) treatment of ex vivo CD1 mouse sperm, quantitative Western blot (HiBiT), sperm motility assay, in vitro fertilization assay\",\n      \"journal\": \"Journal of medicinal chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — chemical knockdown in native sperm with quantitative protein reduction and two orthogonal functional readouts (motility and IVF), single lab\",\n      \"pmids\": [\"42228803\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"TSSK2 is a testis-specific serine/threonine kinase expressed post-meiotically in elongating spermatids and localized to the sperm head/post-acrosomal region; it phosphorylates the axoneme protein SPAG16L and the N-terminal domain of TSKS, associates with translation initiation factors and ribosomal proteins as part of the late chromatoid body to regulate mRNA translation during late spermatogenesis, and is individually essential for sperm motility, sperm number, and male fertility as demonstrated by CRISPR knockout and acute targeted degradation in sperm.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"TSSK2 is a testis-specific serine/threonine protein kinase that is individually essential for sperm motility, sperm number, and male fertility [#5]. Recombinant human TSSK2 is enzymatically active with a low ATP Km and is potently inhibited by staurosporine and by pyrrolopyrimidine/pyrimidine small molecules at sub-100 nM potency [#1, #2]. Its identified substrates include the axoneme central-apparatus protein SPAG16L, which it binds via the SPAG16L C-terminal WD-repeat domain and phosphorylates in vitro, and the N-terminal region (aa 1–150) of TSKS [#0, #1]; TSSK2 protein is markedly reduced in SPAG16L-null testes, indicating that the interaction also stabilizes TSSK2 [#0]. In elongating spermatids TSSK2 is a component of the late chromatoid body, where it associates with translation initiation factors and ribosomal proteins and co-precipitates a defined set of polysome-enriched mRNAs, linking the kinase to temporally regulated translation during late spermatogenesis [#6]. Genetic ablation produces sterile males with reduced and poorly motile sperm, and acute PROTAC-mediated degradation of TSSK2 in ex vivo sperm collapses motility and fertilizing capacity within hours, establishing that ongoing TSSK2 kinase activity is required for sperm function [#5, #7].\",\n  \"teleology\": [\n    {\n      \"year\": 2008,\n      \"claim\": \"Established the first molecular substrate and binding partner of TSSK2, connecting the kinase to the sperm axoneme.\",\n      \"evidence\": \"Yeast two-hybrid, reciprocal Co-IP, in vitro kinase assay, domain mapping, and KO mouse immunoblot identifying SPAG16L\",\n      \"pmids\": [\"18367677\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Phosphosite on SPAG16L not mapped\", \"Functional consequence of SPAG16L phosphorylation in vivo not tested\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Defined the subcellular distribution of TSSK2 in mature sperm and distinguished it from TSSK1.\",\n      \"evidence\": \"Immunofluorescence of non-capacitated, capacitated, and acrosome-reacted mouse and human sperm\",\n      \"pmids\": [\"22855445\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No functional consequence directly tied to TSSK2 localization\", \"Species difference (post-acrosomal vs equatorial) unexplained\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Addressed whether TSSK2 and its paralog TSSK1B are functionally redundant by comparing selective pressures and a human variant.\",\n      \"evidence\": \"Comparative primate genomics with functional mutagenesis of the K27R variant\",\n      \"pmids\": [\"23258646\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"K27R mutagenesis lacks a described biochemical readout\", \"Differential function inferred from evolution, not directly demonstrated\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Confirmed TSSK2 is an active kinase with defined substrates and kinetics, mapping its primary site on TSKS.\",\n      \"evidence\": \"Baculovirus-expressed recombinant human TSSK2, in vitro kinase assays, TSKS fragment phosphorylation mapping, ATP Km and staurosporine IC50 determination\",\n      \"pmids\": [\"26777341\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological role of TSKS phosphorylation not established\", \"No structural model of the active kinase\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Demonstrated TSSK2 is a chemically tractable target and profiled inhibitor selectivity across TSSK isoforms.\",\n      \"evidence\": \"High-throughput mobility-shift screen of ~17,000 compounds with IC50 profiling across TSSK1/2/3/6\",\n      \"pmids\": [\"28952188\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Inhibitor activity in sperm not tested in this study\", \"Selectivity against the broader kinome not reported\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Established that TSSK2 is individually essential for male fertility, independent of TSSK1.\",\n      \"evidence\": \"CRISPR/Cas9 knockout mice, mating and IVF fertility assays, sperm count and motility analysis, validated-antibody immunofluorescence\",\n      \"pmids\": [\"40305308\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular cause of the motility/count defect not resolved\", \"Stage at which spermatogenesis fails not pinpointed\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Placed TSSK2 in the late chromatoid body and linked it to temporally regulated mRNA translation in elongating spermatids.\",\n      \"evidence\": \"Protein and RNA interaction profiling, polysome fractionation, late-CB marker co-localization\",\n      \"pmids\": [\"41042594\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether TSSK2 kinase activity controls the associated translation not shown\", \"Identity of functionally relevant mRNA targets not validated\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Showed that acute, post-developmental loss of TSSK2 protein is sufficient to abolish sperm motility and fertilization, validating it as a non-hormonal contraceptive target.\",\n      \"evidence\": \"PROTAC-mediated degradation in ex vivo mouse sperm with HiBiT quantification, motility and IVF readouts\",\n      \"pmids\": [\"42228803\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Reversibility and in vivo efficacy not addressed\", \"Mechanism linking acute kinase loss to motility collapse not defined\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How TSSK2 kinase activity mechanistically couples its substrates (SPAG16L, TSKS) and its chromatoid-body translational role to sperm motility remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No in vivo phosphosite-mutant rescue connecting substrate phosphorylation to motility\", \"Causal link between late-CB translation and the knockout phenotype untested\", \"Structure of TSSK2 and its substrate-recognition basis unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 1, 2]},\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [0, 1]},\n      {\"term_id\": \"GO:0003723\", \"supporting_discovery_ids\": [6]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [6]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1474165\", \"supporting_discovery_ids\": [5, 7]},\n      {\"term_id\": \"R-HSA-8953854\", \"supporting_discovery_ids\": [6]}\n    ],\n    \"complexes\": [\"late chromatoid body\"],\n    \"partners\": [\"SPAG16L\", \"TSKS\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":5,"faith_total":5,"faith_pct":100.0}}